Sign Up to like & get
recommendations!
0
Published in 2020 at "Biochemical pharmacology"
DOI: 10.1016/j.bcp.2020.114023
Abstract: Cisplatin is the most commonly used chemotherapeutic drug for nasopharyngeal carcinoma (NPC), while its side effects are often intolerable. Lobaplatin, as an effective third-generation platinum with fewer adverse reactions and less platinum cross-resistance, has been…
read more here.
Keywords:
ciap1;
cisplatin;
lobaplatin;
nasopharyngeal carcinoma ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2024 at "Cancer Research"
DOI: 10.1158/1538-7445.am2024-5088
Abstract: STK11 is a serine-threonine kinase and tumor suppressor lost in about 25% of NSCLC. It potently regulates a network of downstream effector kinases in the AMPK family, thereby exerting major effects on cell signaling, metabolic…
read more here.
Keywords:
cancer;
resistance;
traf2;
ciap1 ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2021 at "Chinese Medicine"
DOI: 10.1186/s13020-021-00426-1
Abstract: Background Shikonin (SKO) is a natural naphthoquinone derived from Chinese herbal medicine Arnebiae Radix with high development potentials due to its anti-inflammatory and anti-tumor activities. Overwhelming evidences have indicated that SKO can induce both necrosis and…
read more here.
Keywords:
necrosis;
degradation;
medicine;
apoptosis ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Oncology reports"
DOI: 10.3892/or.2022.8290
Abstract: Cellular inhibitor of apoptosis protein‑1 (cIAP1) is a key regulator of programmed cell death and is known to be associated with chemotherapeutic resistance. The present study aimed to investigate the antitumor efficacy of birinapant, a…
read more here.
Keywords:
chemotherapy;
cddp;
inhibition;
ciap1 ... See more keywords